Navigation Links
Stereotaxis Receives Commitment to Increase and Extend Credit Facility
Date:11/10/2010

ST. LOUIS, Nov. 10, 2010 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that the Company has received a commitment letter from Silicon Valley Bank for an amended credit agreement that extends its revolving $30 million credit facility to March 31, 2012.  Consistent with the current agreement, the revolving line of credit commitment includes a sublimit of $10 million for advances guaranteed by two current shareholders.  The commitment also provides an additional $10 million term loan that matures on January 1, 2014.

"Our two primary objectives in negotiating an amendment to the facility were to extend the current revolving facility to March of 2012 and to obtain a longer maturity term loan to bridge the Company's capital structure through the repayment of other obligations due by the end of 2011.  This combined facility allows for additional financial flexibility as we continue to focus on driving commercial success of our technology platforms," said Mike Kaminski, Chief Executive Officer of Stereotaxis.

The commitment is contingent upon the Company raising $10 million in additional equity, completion of definitive loan documents and other typical closing conditions as well as the recently completed extension of the $10 million guarantee from two shareholders. Stereotaxis reached an agreement with these shareholders to extend their guarantee through March 31, 2012 in exchange for warrants to purchase an aggregate of 800,000 shares of Stereotaxis common stock.  The exercise price of these shares will be the greater of 10% above the November 2010 underwritten offering price or the closing bid price on November 10, 2010.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treat
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program
2. Stereotaxis Reports Third Quarter Financial Results
3. Stereotaxis Appoints Industry Veteran as Head of EMEA Sales and Operations
4. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
5. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
6. Stereotaxis Announces Third Quarter 2010 Capital Orders of $12.2 Million, Up 94 Percent Year-to-Year
7. Stereotaxis to Present at the JMP Securities Healthcare Conference
8. Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent
9. Stereotaxis to Present at the CL King Best Ideas Conference and the Stifel Nicolaus Healthcare Conference
10. Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
11. Stereotaxis Announces Second Quarter 2010 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... CUPERTINO, Calif. , March 30, 2015 /PRNewswire/ ... announced that it has initiated a multi-dose Phase ... DUR-928, the lead molecule in DURECT,s Epigenomic Regulator ... entity (NCE) that may have broad applicability in ... (NAFLD) and nonalcoholic steatohepatitis (NASH).  It may also ...
(Date:3/30/2015)... Sorrento Therapeutics, Inc. (Nasdaq: SRNE ) ... to the position of Executive Vice President & ... be responsible for all legal, compliance and intellectual property ... BioDelivery Sciences International, Inc., where he was Senior Vice ... management that led that company to over a six ...
(Date:3/30/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... the investment community and media on the company,s diabetes ... 75th American Diabetes Association® Scientific Sessions, will include multiple ... review of the Phase III data for basal insulin ... The meeting will be held from 7-8:30 ...
Breaking Medicine Technology:DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3Lilly Announces Date for Diabetes Investor Meeting 2
... ABBOTT PARK, Ill., Feb. 8 A new diagnostic ... form of ovarian cancer may soon be available in the ... simple blood test to help in monitoring for the recurrence or ... be the first automated HE4 test available in the United ...
... HAYWARD, Calif. , Feb. 8 Anthera ... treat serious diseases associated with inflammation, announced today that it ... (FDA) on a Special Protocol Assessment (SPA) for the Phase ... Acute Coronary Syndrome - 16 Weeks) for its lead product ...
Cached Medicine Technology:Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval 2Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval 3Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors 2Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors 3
(Date:3/30/2015)... Los Angeles, CA (PRWEB) March 30, 2015 ... “6 New Ways to Blast Away Fat,” details six new ... these treatments require injections and one is a topical product. ... ( UltraShape and Liposonix ) or freezing cold ... “There are so many options now available to us to ...
(Date:3/30/2015)... 30, 2015 In a recent report ... Governor Chris Christie is championing effective drug and alcohol ... is scrambling to recover funds to stabilize the addiction ... for victims of drug and alcohol addiction. Harbor Village ... plagued by substance use disorders in New Jersey, in ...
(Date:3/30/2015)... This report studies the global pharmacovigilance and drug ... 2014 to 2019. This market is expected to ... to 2019. , Further Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=16831714 ... and drug safety software market has been classified ... namely, adverse event reporting software, drug safety audits ...
(Date:3/30/2015)... 2015 Dr. Daniel Shapiro, one of the ... recently featured on Phoenix’s Channel 12 News about the benefits ... minimally invasive alternative to facelifts developed by Dr. Shapiro. , ... at Shapiro Aesthetic Plastic Surgery and Skin Klinic worked closely ... news story on GenXLift. The story detailed the experience and ...
(Date:3/30/2015)... GenSight ®, provider of an Enterprise Portfolio Management ... Forrester Wave™: Strategic Planning For The [Business Technology] BT ... GenSight as a leader and gave the company the ... analytics, corporate strategy, assessment, direction and life cycle support ... Leaders category. , According to the report: GenSight ...
Breaking Medicine News(10 mins):Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:Dr. Daniel Shapiro Unveils New Minimally Invasive Facelift Procedure on Local Newscast 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3
... never make it big in Hollywood as she feels she is too ... short impedes her. She says: I don't think that's ever going to ... tend to look really small on camera. ,'I can probably ... to be it. I have a feeling I am way too small.' ...
... workers who were abducted by Taliban at gunpoint were ... that they were all health workers. // They abduction ... militants snatched on Thursday a vehicle carrying the 15 ... after their identity was made clear, Outlook newspaper quoted ...
... like angioplasty are the various treatments for people ... is a small industrial city in northeast Ohio. ... the country, would suggest their patients to go ... balloon catheters through arteries and sometimes placing drug-coated ...
... Nepal have irked student organizations who came out on the ... roads and stoned vehicles and burnt tyres on the streets. ... population of Nepal is furious with the price hike, which ... student wings of two of the leading parties in the ...
... reports of moderate iodine deficiency among New Zealanders and ... the Trans-Tasman regulator// Food Standards Australia New Zealand (FSANZ) ... iodized salt in some common household products. Recent ... not getting enough of iodine. ,The proposal by ...
... Scientists have achieved a very important milestone in the mapping ... enhance the health and aid better disease// control in cattle. ... industry immensely. ,Scientists firmed up on a sequence ... the value of the difference even in one pair, which ...
Cached Medicine News:Health News:Heart Procedure numbers go haywire in an Ohio City 2Health News:Fuel Price Hike Triggers Violent Protests In Nepal 2Health News:Fuel Price Hike Triggers Violent Protests In Nepal 3
... is a fully adjustable, air-displacement pipette with ... the latest member of the Pipetman family, ... accuracy, and precision. We also added a ... our customers. Eight models cover the full ...
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 0.5-10 microliter range....
Medicine Products: